Published: Feb 04, 2021 By Brandon May
Michael Vi / Shutterstock
Amgen is in the process of eliminating hundreds of U.S. jobs, the majority of which are centered on the company’s sales team, according to a recent sales call. The California-based company indicates these layoffs will enable Amgen to make investments in other opportunities, such as new product launches and R&D operations.
In an announcement of the company’s fourth-quarter and full-year 2020 financial results, Amgen reported a 9% growth in sales of $25.4 billion. Volume growth primarily contributed to these gains, but lower net selling prices, as well as the pandemic, offset the overall gains.